Back
CRISPR Therapeutics AG Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
27
CRSP
CRISPR Therapeutics AG
Last Price:
$35.61
Seasonality Move:
22.33%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.43 | Sell |
| 20-day SMA: | 37.62 | Sell |
| 50-day SMA: | 38.67 | Sell |
| 200-day SMA: | 44.81 | Sell |
| 8-day EMA: | 36.13 | Sell |
| 20-day EMA: | 35.72 | Sell |
| 50-day EMA: | 28.14 | Buy |
| 200-day EMA: | 11.17 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.89 | Buy |
| Relative Strength Index (14 RSI): | 44.75 | Sell |
| Chaikin Money Flow: | -1595700 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.33 - 39.09) | Sell |
| Bollinger Bands (100): | (36.6 - 44.6) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 35.62 while CRSP 8-day simple moving average is 36.43, which is a Sell signal.
-
The stock price of CRSP is 35.62 while CRISPR Therapeutics AG 20-day SMA is 37.62, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 38.67 while CRSP share price is 35.62, making it a Sell technically.
-
CRSP stock price is 35.62 and CRISPR Therapeutics AG 200-day simple moving average is 44.81, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
27
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $35.62. The Score for CRSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.1B
Price in USD:
35.62
Share Volume:
1.7M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
67.88
52-Week Low:
30.04
Sell
27
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 35.62 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 35.62 while CRSP 8-day exponential moving average is 36.13, which is a Sell signal.
-
The stock price of CRSP is 35.62 while CRISPR Therapeutics AG 20-day EMA is 35.72, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day exponential moving average is 28.14 while CRSP share price is 35.62, making it a Buy technically.
-
CRSP stock price is 35.62 and CRISPR Therapeutics AG 200-day simple moving average is 11.17, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.24 per share, and an increase next year of $1.00 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 1.89, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 44.75, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (34.33 - 39.09), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (36.6 - 44.6), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.